
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors Inc. has demonstrated financial strength by raising its normalized funds from operations (NFFO) estimates, with a new projection of $4.80 per share for 2025, which aligns with management's guidance range. Additionally, the company's 2026 FFO estimate has been adjusted upwards to $5.03 per share, surpassing the $5.00 consensus, signaling robust performance expectations. These upward revisions in key financial metrics reflect a positive outlook for the company's future growth and operational efficiency within its real estate and healthcare segments.
Bears say
National Health Investors Inc. faces a negative outlook due to expected lower earnings growth in the coming years, which stems from the interplay between accretive acquisition activities and potential operational challenges among its tenants. The company may encounter financial underperformance if the NHC rent reset falls short of investor expectations and if there are weaknesses in deferred rent collections, which could be exacerbated by potential future pandemic-related issues. Additionally, difficulties experienced by one or more operators could further impact the company’s revenue streams derived from rental income and other patient services.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares